Nestlé : OPA amicale sur Aimmune Therapeutics pour créer un leader mondial dans le traitement des allergies alimentaires
>Maintien du cap stratégique - Achat maintenu. Avec l’annonce de l’OPA sur Aimmune Therapeutics, Nestlé montre de nouveau qu’il maintient son cap stratégique de transformation de son portefeuille, malgré le contexte compliqué. Le prix proposé est forcément élevé pour une cible qui ne réalise aucun CA. Mais le potentiel est important et surtout Aimmune apporte le 3ème pilier de la Nutrition médicale : le traitement des allergies alimentaires. OPA amicale s...Nestle is a holding company which is based in Switzerland. Through its subsidiaries and allied companies, Co. is engaged in the food processing industry. Co.'s product portfolio has seven categories, Powder and Liquid Beverages, Nutritional and Health Science, Milk products and ice cream, Prepared dishes and cooking aids, PetCare, Confectionery and Water.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.